Meddenovo Drug Design

Startup

Meddenovo Drug Design has developed an advanced technology platform to aid drug developers in crafting innovative drug candidates in the field of peptides.

Cyclic peptides hold tremendous promise as therapeutic agents for a wide range of diseases that currently lack effective treatments. Despite their potential, the development of peptide-based drugs has been hindered by the absence of specialized design tools. Our platform addresses this challenge by integrating unique market software with the largest database of peptide-like medicines. It is uniquely optimized for the design of cyclic peptides, utilizing a seamless blend of artificial intelligence and physical computational techniques.

Our platform is accessible to drug hunters around the world via service and co-development options right now. By 2025, users will have direct access to the Meddenovo Drug Design platform to test their own unique ideas or to further develop their novel candidates, accelerating their drug development process.

website